• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗女性性工作者中艾滋病病毒暴露前预防的成本效益

Cost-effectiveness of HIV pre-exposure prophylaxis among female sex workers in Iran.

作者信息

Moameri Hossein, Goudarzi Reza, Haghdoost Ali Akbar, Gouya Mohammad Mehdi, Saberi Parya, Mirzazadeh Ali, Shahrbabaki Parvin Mangolian, Sharifi Hamid

机构信息

Student Research Committee, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran.

Health Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

出版信息

Sci Rep. 2025 Mar 5;15(1):7747. doi: 10.1038/s41598-025-92099-1.

DOI:10.1038/s41598-025-92099-1
PMID:40044976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11882906/
Abstract

The Iranian government does not fund pre-exposure prophylaxis (PrEP), and it is not used in Iran due to uncertainties in its cost-effectiveness. In this study, we examined the cost-effectiveness of PrEP among female sex workers (FSWs) in Iran. The cost-effectiveness analysis compared only PrEP, a combination of PrEP with harm reduction (HR) with only HR scenario among FSWs over a 10-year time horizon. The perspective of the healthcare provider was used in the analysis. The primary outcome was disability-adjusted life year (DALY) averted. Analyses included health and cost outcomes, as well as the incremental cost-effectiveness ratio (ICER), which was reported as the cost per DALY averted. Only PrEP was not cost-effective at a willingness to pay threshold of 4669.6 USD per DALY averted in Iran. In contrast, PrEP and HR strategies were cost-effective at the same willingness to pay threshold. The ICER was 868.47 USD per DALY averted for PrEP and HR compared to HR alone. Compared to HR, combining PrEP with HR is a cost-effective intervention among Iranian FSWs for reducing the clinical and economic burden associated with HIV over a 10-year time horizon. Iran should add PrEP to current HR programs for FSWs.

摘要

伊朗政府不资助暴露前预防(PrEP),并且由于其成本效益存在不确定性,PrEP在伊朗未被使用。在本研究中,我们考察了PrEP在伊朗女性性工作者(FSW)中的成本效益。成本效益分析仅比较了PrEP、PrEP与减少伤害(HR)相结合以及仅采用HR方案这三种情况,时间跨度为10年,针对女性性工作者群体。分析采用了医疗服务提供者的视角。主要结局指标是避免的伤残调整生命年(DALY)。分析包括健康和成本结局,以及增量成本效益比(ICER),以每避免一个DALY的成本来报告。在伊朗,以每避免一个DALY支付意愿阈值为4669.6美元时,仅PrEP不具有成本效益。相比之下,PrEP与HR策略在相同支付意愿阈值下具有成本效益。与仅采用HR相比,PrEP与HR相结合时的ICER为每避免一个DALY 868.47美元。在10年时间跨度内,与HR相比,PrEP与HR相结合对于减轻伊朗女性性工作者中与艾滋病毒相关的临床和经济负担而言,是一种具有成本效益的干预措施。伊朗应将PrEP纳入当前针对女性性工作者的减少伤害项目中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/331434506fd0/41598_2025_92099_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/32ac249d6937/41598_2025_92099_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/a834ff32b188/41598_2025_92099_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/55e94c631df0/41598_2025_92099_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/6427b7b6a4aa/41598_2025_92099_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/331434506fd0/41598_2025_92099_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/32ac249d6937/41598_2025_92099_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/a834ff32b188/41598_2025_92099_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/55e94c631df0/41598_2025_92099_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/6427b7b6a4aa/41598_2025_92099_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae9f/11882906/331434506fd0/41598_2025_92099_Fig5_HTML.jpg

相似文献

1
Cost-effectiveness of HIV pre-exposure prophylaxis among female sex workers in Iran.伊朗女性性工作者中艾滋病病毒暴露前预防的成本效益
Sci Rep. 2025 Mar 5;15(1):7747. doi: 10.1038/s41598-025-92099-1.
2
Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis.南非异性恋男性中 HIV 暴露前预防的成本效益:成本效用建模分析。
J Acquir Immune Defic Syndr. 2020 Jun 1;84(2):173-181. doi: 10.1097/QAI.0000000000002327.
3
Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.双夫定阴道环预防艾滋病毒:建模健康结果、耐药性和成本效益。
J Int AIDS Soc. 2019 May;22(5):e25282. doi: 10.1002/jia2.25282.
4
Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel.以色列男男性行为人群中 HIV 暴露前预防的成本效用分析。
BMC Public Health. 2020 Feb 27;20(1):271. doi: 10.1186/s12889-020-8334-4.
5
Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.国家扩大南非女性性工作者艾滋病毒暴露前预防规模的影响和成本效益:建模分析。
J Int AIDS Soc. 2023 Feb;26(2):e26063. doi: 10.1002/jia2.26063.
6
Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.撒哈拉以南非洲地区孕期及哺乳期艾滋病病毒暴露前预防的成本效益
J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2(Suppl 2):S145-53. doi: 10.1097/QAI.0000000000001063.
7
Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China.在中国男男性行为者中进行 HIV 预防用药的流行病学影响和成本效益建模。
AIDS Behav. 2019 Feb;23(2):523-533. doi: 10.1007/s10461-018-2205-3.
8
Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.模拟口服暴露前预防在 13 个资源匮乏国家的影响和成本效益。
J Int AIDS Soc. 2020 Feb;23(2):e25451. doi: 10.1002/jia2.25451.
9
Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.在南非,为注射式避孕使用者提供长效暴露前预防措施以预防 HIV 的流行病学影响和成本效益:一项建模研究。
J Int AIDS Soc. 2019 Dec;22(12):e25427. doi: 10.1002/jia2.25427.
10
Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.中泰两国两所医院男男性行为者中开展暴露前预防的成本及成本效益分析。
J Int AIDS Soc. 2018 Jul;21 Suppl 5(Suppl Suppl 5):e25129. doi: 10.1002/jia2.25129.

本文引用的文献

1
Implementation and resource needs for long-acting PrEP in low- and middle-income countries: a scoping review.中低收入国家长效预防用 PrEP 的实施和资源需求:范围综述。
J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26110. doi: 10.1002/jia2.26110.
2
Methods for Communicating the Impact of Parameter Uncertainty in a Multiple-Strategies Cost-Effectiveness Comparison.在多策略成本效益比较中沟通参数不确定性影响的方法。
Med Decis Making. 2022 Oct;42(7):956-968. doi: 10.1177/0272989X221100112. Epub 2022 May 19.
3
Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations.
口服暴露前预防(PrEP)预防 HIV:对所有人群的临床效果、安全性、依从性和风险补偿的系统评价和荟萃分析。
BMJ Open. 2022 May 11;12(5):e048478. doi: 10.1136/bmjopen-2020-048478.
4
Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data.提高男男性行为者对 HIV 暴露前预防 (PrEP) 的认识和使用 HIV PrEP 的意愿:全球数据的系统评价和荟萃分析。
J Int AIDS Soc. 2022 Mar;25(3):e25883. doi: 10.1002/jia2.25883.
5
A systematic and meta-analysis of heterosexual behaviors and HIV prevalence among Chinese men who have sex with men.一项关于中国男男性行为者异性性行为和 HIV 流行率的系统和荟萃分析。
AIDS Res Ther. 2021 Oct 10;18(1):68. doi: 10.1186/s12981-021-00392-6.
6
Efficiency in PrEP Delivery: Estimating the Annual Costs of Oral PrEP in Zimbabwe.PrEP 提供的效率:估算津巴布韦口服 PrEP 的年度成本。
AIDS Behav. 2022 Jan;26(1):161-170. doi: 10.1007/s10461-021-03367-w. Epub 2021 Aug 27.
7
Equity considerations in outcome measures of the HIV pre-exposure prophylaxis care continuum in high-income countries: a systematic review protocol.高收入国家中 HIV 暴露前预防护理连续体结局指标中的公平性考虑因素:系统评价方案。
BMJ Open. 2021 Feb 4;11(2):e040701. doi: 10.1136/bmjopen-2020-040701.
8
HIV in Iran: onset, responses, and future directions.伊朗的艾滋病毒:发病情况、应对措施和未来方向。
AIDS. 2021 Mar 15;35(4):529-542. doi: 10.1097/QAD.0000000000002757.
9
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.终结美国六大城市注射吸毒人群中的艾滋病毒流行:一项成本效益分析
J Infect Dis. 2020 Sep 2;222(Suppl 5):S301-S311. doi: 10.1093/infdis/jiaa130.
10
Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis.南非异性恋男性中 HIV 暴露前预防的成本效益:成本效用建模分析。
J Acquir Immune Defic Syndr. 2020 Jun 1;84(2):173-181. doi: 10.1097/QAI.0000000000002327.